AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Phibro Animal Health Corporation Statistics
Share Statistics
Phibro Animal Health Corporation has 40.50M shares outstanding. The number of shares has increased by 0% in one year.
Shares Outstanding | 40.50M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 39.77M |
Failed to Deliver (FTD) Shares | 65 |
FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 770.81K, so 1.9% of the outstanding shares have been sold short.
Short Interest | 770.81K |
Short % of Shares Out | 1.9% |
Short % of Float | 1.94% |
Short Ratio (days to cover) | 4.77 |
Valuation Ratios
The PE ratio is 285.67 and the forward PE ratio is 13.33. Phibro Animal Health Corporation's PEG ratio is 0.09.
PE Ratio | 285.67 |
Forward PE | 13.33 |
PS Ratio | 0.68 |
Forward PS | 0.6 |
PB Ratio | 2.69 |
P/FCF Ratio | 14.89 |
PEG Ratio | 0.09 |
Enterprise Valuation
Phibro Animal Health Corporation has an Enterprise Value (EV) of 1.02B.
EV / Earnings | 423.67 |
EV / Sales | 1.01 |
EV / EBITDA | 12.1 |
EV / EBIT | 19.2 |
EV / FCF | 22.08 |
Financial Position
The company has a current ratio of 2.94, with a Debt / Equity ratio of 2.05.
Current Ratio | 2.94 |
Quick Ratio | 1.64 |
Debt / Equity | 2.05 |
Total Debt / Capitalization | 67.19 |
Cash Flow / Debt | 0.17 |
Interest Coverage | 2.43 |
Financial Efficiency
Return on equity (ROE) is 0.01% and return on capital (ROIC) is 1.51%.
Return on Equity (ROE) | 0.01% |
Return on Assets (ROA) | 0% |
Return on Capital (ROIC) | 1.51% |
Revenue Per Employee | 524.58K |
Profits Per Employee | 1.25K |
Employee Count | 1.94K |
Asset Turnover | 1.04 |
Inventory Turnover | 2.65 |
Taxes
Income Tax | 8.50M |
Effective Tax Rate | 0.78 |
Stock Price Statistics
The stock price has increased by 78.07% in the last 52 weeks. The beta is 0.51, so Phibro Animal Health Corporation's price volatility has been higher than the market average.
Beta | 0.51 |
52-Week Price Change | 78.07% |
50-Day Moving Average | 22.73 |
200-Day Moving Average | 19.53 |
Relative Strength Index (RSI) | 35.99 |
Average Volume (20 Days) | 178.10K |
Income Statement
In the last 12 months, Phibro Animal Health Corporation had revenue of 1.02B and earned 2.42M in profits. Earnings per share was 0.06.
Revenue | 1.02B |
Gross Profit | 313.09M |
Operating Income | 53.31M |
Net Income | 2.42M |
EBITDA | 84.61M |
EBIT | 53.31M |
Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 70.61M in cash and 525.46M in debt, giving a net cash position of -454.85M.
Cash & Cash Equivalents | 70.61M |
Total Debt | 525.46M |
Net Cash | -454.85M |
Retained Earnings | 243.89M |
Total Assets | 966.29M |
Working Capital | 393.87M |
Cash Flow
In the last 12 months, operating cash flow was 87.59M and capital expenditures -41.24M, giving a free cash flow of 46.36M.
Operating Cash Flow | 87.59M |
Capital Expenditures | -41.24M |
Free Cash Flow | 46.36M |
FCF Per Share | 1.14 |
Margins
Gross margin is 30.77%, with operating and profit margins of 5.24% and 0.24%.
Gross Margin | 30.77% |
Operating Margin | 5.24% |
Pretax Margin | 1.07% |
Profit Margin | 0.24% |
EBITDA Margin | 8.31% |
EBIT Margin | 5.24% |
FCF Margin | 4.56% |
Dividends & Yields
PAHC pays an annual dividend of $0.48, which amounts to a dividend yield of 2.37%.
Dividend Per Share | $0.48 |
Dividend Yield | 2.37% |
Dividend Growth (YoY) | 0% |
Payout Ratio | 111.63% |
Earnings Yield | 0.3% |
FCF Yield | 5.64% |
Analyst Forecast
The average price target for PAHC is $21, which is 3.4% higher than the current price. The consensus rating is "Hold".
Price Target | $21 |
Price Target Difference | 3.4% |
Analyst Consensus | Hold |
Analyst Count | 4 |
Scores
Altman Z-Score | 2.87 |
Piotroski F-Score | 7 |